BNP Paribas Financial Markets’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.5M | Sell |
215,639
-108,679
| -34% | -$1.92M | ﹤0.01% | 2295 |
|
|
2025
Q4 | $6.07M | Sell |
324,318
-49,282
| -13% | -$817K | ﹤0.01% | 1914 |
|
|
2025
Q3 | $5.45M | Sell |
373,600
-13,872
| -4% | -$175K | ﹤0.01% | 1916 |
|
|
2025
Q2 | $4.27M | Buy |
387,472
+91,300
| +31% | +$888K | ﹤0.01% | 1960 |
|
|
2025
Q1 | $2.64M | Sell |
296,172
-9,443
| -3% | -$87.9K | ﹤0.01% | 2185 |
|
|
2024
Q4 | $2.88M | Buy |
305,615
+135
| +0% | +$1.23K | ﹤0.01% | 2158 |
|
|
2024
Q3 | $2.46M | Buy |
305,480
+143,781
| +89% | +$1.25M | ﹤0.01% | 1939 |
|
|
2024
Q2 | $1.37M | Buy |
161,699
+128,241
| +383% | +$1.16M | ﹤0.01% | 2115 |
|
|
2024
Q1 | $300K | Buy |
33,458
+7,851
| +31% | +$72.7K | ﹤0.01% | 3111 |
|
|
2023
Q4 | $288K | Buy |
25,607
+11,813
| +86% | +$119K | ﹤0.01% | 3083 |
|
|
2023
Q3 | $119K | Sell |
13,794
-2,488
| -15% | -$24K | ﹤0.01% | 3281 |
|
|
2023
Q2 | $169K | Sell |
16,282
-2,922
| -15% | -$32.3K | ﹤0.01% | 3073 |
|
|
2023
Q1 | $208K | Sell |
19,204
-24,397
| -56% | -$258K | ﹤0.01% | 3128 |
|
|
2022
Q4 | $489K | Buy |
43,601
+27,644
| +173% | +$291K | ﹤0.01% | 2588 |
|
|
2022
Q3 | $162K | Sell |
15,957
-92,693
| -85% | -$869K | ﹤0.01% | 3578 |
|
|
2022
Q2 | $984K | Sell |
108,650
-15,584
| -13% | -$144K | ﹤0.01% | 2216 |
|
|
2022
Q1 | $1.19M | Buy |
124,234
+47,509
| +62% | +$466K | ﹤0.01% | 2200 |
|
|
2021
Q4 | $848K | Buy |
76,725
+65,935
| +611% | +$575K | ﹤0.01% | 2703 |
|
|
2021
Q3 | $79.8K | Buy |
10,790
+8,717
| +421% | +$97.5K | ﹤0.01% | 3365 |
|
|
2021
Q2 | $30.1K | Sell |
2,073
-4,955
| -71% | -$93K | ﹤0.01% | 3427 |
|
|
2021
Q1 | $143K | Sell |
7,028
-2,721
| -28% | -$51.7K | ﹤0.01% | 3188 |
|
|
2020
Q4 | $173K | Sell |
9,749
-1,255
| -11% | -$22.5K | ﹤0.01% | 2955 |
|
|
2020
Q3 | $163K | Buy |
11,004
+7,953
| +261% | +$149K | ﹤0.01% | 2854 |
|
|
2020
Q2 | $64K | Sell |
3,051
-12,880
| -81% | -$331K | ﹤0.01% | 2944 |
|
|
2020
Q1 | $368K | Buy |
15,931
+9,802
| +160% | +$245K | ﹤0.01% | 2529 |
|
|
2019
Q4 | $159K | Sell |
6,129
-1,750
| -22% | -$34K | ﹤0.01% | 3067 |
|
|
2019
Q3 | $153K | Buy |
7,879
+2,088
| +36% | +$42.2K | ﹤0.01% | 2892 |
|
|
2019
Q2 | $94.6K | Sell |
5,791
-4,174
| -42% | -$84.6K | ﹤0.01% | 3066 |
|
|
2019
Q1 | $226K | Buy |
9,965
+8,951
| +883% | +$227K | ﹤0.01% | 2622 |
|
|
2018
Q4 | $25.9K | Sell |
1,014
-1,363
| -57% | -$36.8K | ﹤0.01% | 3008 |
|
|
2018
Q3 | $77.7K | Buy |
2,377
+180
| +8% | +$4.91K | ﹤0.01% | 2878 |
|
|
2018
Q2 | $49.8K | Sell |
2,197
-6,863
| -76% | -$163K | ﹤0.01% | 3122 |
|
|
2018
Q1 | $220K | Buy |
9,060
+395
| +5% | +$10.8K | ﹤0.01% | 2741 |
|
|
2017
Q4 | $242K | Buy |
8,665
+3,797
| +78% | +$112K | ﹤0.01% | 2870 |
|
|
2017
Q3 | $167K | Sell |
4,868
-283
| -5% | -$9.25K | ﹤0.01% | 2546 |
|
|
2017
Q2 | $205K | Buy |
5,151
+4,383
| +571% | +$169K | ﹤0.01% | 2437 |
|
|
2017
Q1 | $28.3K | Sell |
768
-1,925
| -71% | -$61.5K | ﹤0.01% | 2923 |
|
|
2016
Q4 | $85.9K | Sell |
2,693
-315
| -10% | -$9.77K | ﹤0.01% | 2591 |
|
|
2016
Q3 | $109K | Buy |
3,008
+1,577
| +110% | +$43.9K | ﹤0.01% | 2059 |
|
|
2016
Q2 | $32.5K | Buy |
+1,431
| New | +$30.9K | ﹤0.01% | 2433 |
|
|
2016
Q1 | – | Sell |
-6,202
| Closed | -$102K | – | 3040 |
|
|
2015
Q4 | $102K | Buy |
6,202
+983
| +19% | +$15.6K | ﹤0.01% | 2321 |
|
|
2015
Q3 | $57.4K | Buy |
5,219
+2,938
| +129% | +$37.4K | ﹤0.01% | 2761 |
|
|
2015
Q2 | $29.7K | Buy |
2,281
+1,721
| +307% | +$26.7K | ﹤0.01% | 2808 |
|
|
2015
Q1 | $9.72K | Buy |
+560
| New | +$10.3K | ﹤0.01% | 2758 |
|
|
2014
Q4 | – | Sell |
-1,406
| Closed | -$32.4K | – | 3057 |
|
|
2014
Q3 | $32.4K | Buy |
+1,406
| New | +$40.8K | ﹤0.01% | 2852 |
|
Other funds holding TBPH
MAP
WAM
NM
ICM
VCM
